Persistent Bordetella bronchiseptica pneumonia in an immunocompetent infant and genetic comparison of clinical isolates with kennel cough vaccine strains

Clinical Infectious Diseases

Volumn 46, Issue 6, 2008, Pages 905-908

  Rath, Barbara A ^a,e   Register, Karen B ^d   Wall, Jeffrey ^b   Sokol, Dawn M ^c   Van Dyke, Russell B ^a  

^a TULANE UNIVERSITY HEALTH SCIENCES CENTER   (United States)

^b LOUISIANA STATE UNIV MEDICAL CENTER   (United States)

^c Ochsner Hospital for Children   (United States)

^d AGRICULTURAL RESEARCH SERVICE   (United States)

^e MEDICAL UNIVERSITY OF VIENNA   (Austria)

Author keywords

[No Author keywords available]

Indexed keywords

AZITHROMYCIN; AZTREONAM; CEFEPIME; CEFTRIAXONE; CIPROFLOXACIN; COTRIMOXAZOLE; GENTAMICIN; IMIPENEM; KENNEL COUGH VACCINE; LEVOFLOXACIN; MACROLIDE; PIPERACILLIN PLUS TAZOBACTAM; TIMENTIN; BACTERIAL VACCINE;

ANTIBIOTIC RESISTANCE; ARTICLE; BACTERIAL PNEUMONIA; BACTERIUM CULTURE; BORDETELLA BRONCHISEPTICA; CASE REPORT; CLINICAL FEATURE; DIFFERENTIAL DIAGNOSIS; DISEASE COURSE; DOG; DRUG SUBSTITUTION; DRUG WITHDRAWAL; GENETIC ANALYSIS; HOSPITAL DISCHARGE; HUMAN; IMMUNOCOMPETENCE; IMMUNOFLUORESCENCE TEST; INFANT; INTENSIVE CARE; NUCLEOTIDE SEQUENCE; PERTUSSIS; PRIORITY JOURNAL; RECURRENT DISEASE; RESPIRATORY FAILURE; TREATMENT OUTCOME; ANIMAL; ANIMAL DISEASE; BACTERIAL INFECTION; BACTERIUM IDENTIFICATION; CLASSIFICATION; COUGHING; CULTURE MEDIUM; DOG DISEASE; GENETICS; ISOLATION AND PURIFICATION; MICROBIOLOGICAL EXAMINATION; MICROBIOLOGY;

ANIMALS; BACTERIAL TYPING TECHNIQUES; BACTERIAL VACCINES; BACTERIOLOGICAL TECHNIQUES; BORDETELLA BRONCHISEPTICA; BORDETELLA INFECTIONS; COUGH; CULTURE MEDIA; DOG DISEASES; DOGS; HUMANS; IMMUNOCOMPETENCE; INFANT; PNEUMONIA, BACTERIAL;

EID: 40749146007     PISSN: 10584838     EISSN: None     Source Type: Journal    
DOI: 10.1086/528858     Document Type: Article

References (17)

1. Harvill ET, Preston A, Cotter PA, Allen AG, Maskell DJ, Miller JF. Multiple roles for Bordetella lipopolysaccharide molecules during respiratory tract infection. Infect Immun 2000; 68:6720-8.
2. Parkhill J, Sebaihia M, Preston A, et al. Comparative analysis of the genome sequences of Bordetella pertussis, Bordetella parapertussis, and Bordetella bronchiseptica. Nat Genet 2003; 35:32-40.
3. Bemis DA, Fenwick B. Bordetella. In: Gyles CL, Prescott JF, Songer JG, Thoen CO, eds. Pathogenisis of bacterial infections in animals, 3rd ed. Oxford, UK: Blackwell Publishing, 2004:259-72.
4. Llombart M, Chiner E, Senent C. Necrotizing pneumonia due to Bordetella bronchiseptica in an immunocompetent woman. Arch Bronconeumol 2006; 42:255-6.
5. Woolfrey BF, Moody JA. Human infections associated with Bordetella bronchiseptica. Clin Microbiol Rev 1991; 4:243-55.
6. Stefanelli P, Mastrantonio P, Hausman SZ, Giuliano M, Burns DL. Molecular characterization of two Bordetella bronchiseptica strains isolated from children with coughs. J Clin Microbiol 1997; 35:1550-5.
7. Mattoo S, Cherry JD. Molecular pathogenesis, epidemiology, and clinical manifestations of respiratory infections due to Bordetella pertussis and other Bordetella subspecies. Clin Microbiol Rev 2005; 18:326-82.
8. Berkelman RL. Human illness associated with use of veterinary vaccines. Clin Infect Dis 2003; 37:407-14.
9. Register KB, Boisvert A, Ackermann MR. Use of ribotyping to distinguish Bordetella bronchiseptica isolates. Int J Syst Bacteriol 1997; 47:678-83.
10. Register KB, Magyar T. Optimized ribotyping protocol applied to Hungarian Bordetella bronchiseptica isolates: identification of two novel ribotypes. Vet Microbiol 1999; 69:277-85.
11. Boursaux-Eude C, Guiso N. Polymorphism of repeated regions of pertactin in Bordetella pertussis, Bordetella parapertussis, and Bordetella bronchiseptica. Infect Immun 2000; 68:4815-7.
12. Register KB. Novel genetic and phenotypic heterogeneity in Bordetella bronchiseptica pertactin. Infect Immun 2001; 69:1917-21.
13. Register KB. Comparative sequence analysis of Bordetella bronchiseptica pertactin gene (prn) repeat region variants in swine vaccines and field isolates. Vaccine 2004; 23:48-57.
14. Loeffelholz M, Sanden G. Bordetella pertussis. In: Murray P, Baron E, Jorgensen J, Landry M, Pfaller M, eds. Manual of clinical microbiology, 9th ed. Washington, DC: ASM Press, 2007:803-14.
15. Schneider B, Gross R, Haas A. Phagosome acidification has opposite effects on intracellular survival of Bordetella pertussis and B. bronchiseptica. Infect Immun 2000; 68:7039-48.
16. Register KB, Sanden GN. Prevalence and sequence variants of IS481 in Bordetella bronchiseptica: implications for IS481-based detection of Bordetella pertussis. J Clin Microbiol 2006; 44:4577-83.
17. Huebner ES, Christman B, Dummer S, Tang YW, Goodman S. Hospital-acquired Bordetella bronchiseptica infection following hematopoietic stem cell transplantation. J Clin Microbiol 2006; 44:2581-3.